APA (7th ed.) Citation

EJ, E., & JM, M. (2025). Vaccine Treatment and Evaluation Units: Why Support a "Ready Base" of Clinical Trial Sites? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 81(Supplement_2), S55. https://doi.org/10.1093/cid/ciaf376

Chicago Style (17th ed.) Citation

EJ, Erbelding, and Marrazzo JM. "Vaccine Treatment and Evaluation Units: Why Support a "Ready Base" of Clinical Trial Sites?" Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 81, no. Supplement_2 (2025): S55. https://doi.org/10.1093/cid/ciaf376.

MLA (9th ed.) Citation

EJ, Erbelding, and Marrazzo JM. "Vaccine Treatment and Evaluation Units: Why Support a "Ready Base" of Clinical Trial Sites?" Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 81, no. Supplement_2, 2025, p. S55, https://doi.org/10.1093/cid/ciaf376.